Crystalline hydrochloride salts of c-MET kinase inhibitors

Details for Australian Patent Application No. 2010300930 (hide)

Owner Merck Sharp & Dohme Corp. Merck Sharp & Dohme Limited

Inventors Avalle, Paolo; Chen, Minhua

Agent Spruson & Ferguson

Pub. Number AU-A-2010300930

PCT Pub. Number WO2011/041157

Priority 61/247,028 30.09.09 US

Filing date 21 September 2010

Wipo publication date 7 April 2011

International Classifications

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Event Publications

26 April 2012 PCT application entered the National Phase

  PCT publication WO2011/041157 Priority application(s): WO2011/041157

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.; Merck Sharp & Dohme Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010300941-System and method for using order modifiers in relation to trading strategies

2010300925-Novel compounds that are ERK inhibitors